8.04 USD
↘ 0.15 (1.83%)AT CLOSE (11:59 AM EDT)
Cartesian Therapeutics, Inc. Common Stock
RNACNASDAQ • USD
8.05
↗ 0.01 (0.12%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
8.05
↗ 0.01 (0.12%)
Market: CLOSED
Cartesian Therapeutics, Inc. Common Stock (RNAC) trades at $8.06 per share. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (122.9%) and a bullish Golden Cross on the moving averages. On the valuation front, RNAC trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Sep 14, 2026.
Open?$8.19
High?$8.26
Low?$7.96
Prev. Close?$8.19
Volume?110.2K
Avg. Volume?118.9K
VWAP?$8.07
Rel. Volume?0.93x
Bid / Ask
Bid?$6.02 × 100
Ask?$11.23 × 100
Spread?$5.21
Midpoint?$8.63
Valuation & Ratios
Market Cap?247.8M
Shares Out?30.3M
Float?12.1M
Float %?41.0%
P/E Ratio?N/A
P/B Ratio?-1.98
EPS?-$5.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Themes
Employees
75
Market Cap
247.8M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-22
Address
7495 NEW HORIZON WAY
FREDERICK, MD 21703
Phone: 301-348-8698
FREDERICK, MD 21703
Phone: 301-348-8698
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?35
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?-4.48Distress
Confidence?58%Low
Short InterestVery High
Short % of Float?15.02%High
Short Interest?1.8M
Days to Cover?13.4
Free Float12.1M
Avg Daily Volume135.4K
Settlement Date2026-08-31
Financial Health
Current Ratio?7.48Strong
Quick Ratio?7.48Strong
Cash Ratio?7.18Strong
Debt/Equity?-0.42Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-1.98CHEAP▾
S&P97
P/S?167.77HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.6CHEAP▾
S&P97
EV/Sales?103.61HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?122.9%STRONG▾
Peers50
S&P97
ROA?-48.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$153.0M
Fundamentals ratios updated end of day